Intravenous Ketamine as an Adjunctive Treatment for Dysthymia: A Case Report

Background: Dysthymia, characterized by persistent low mood without reaching the severity of depression, poses a challenge in terms of prolonged symptom duration and limited response to conventional antidepressant therapies. Case description: This case report details the presentation of a patient wi...

Full description

Saved in:
Bibliographic Details
Main Authors: Pavan Kumar Thatisetti Venkata, Divya Bolla, Raj Kiran Donthu
Format: Article
Language:English
Published: Jaypee Brothers Medical Publisher 2024-07-01
Series:Indian Journal of Private Psychiatry
Subjects:
Online Access:https://www.ijiapp.com/doi/IJPP/pdf/10.5005/jp-journals-10067-0173
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Background: Dysthymia, characterized by persistent low mood without reaching the severity of depression, poses a challenge in terms of prolonged symptom duration and limited response to conventional antidepressant therapies. Case description: This case report details the presentation of a patient with dysthymia inadequately responding to antidepressant treatments. Intravenous ketamine was given as an adjunctive treatment, resulting in significant clinical improvement. Conclusion and clinical significance: Our findings suggest that ketamine could serve as a beneficial adjunct in the treatment of dysthymia. However, it is noteworthy that sustained efficacy may necessitate frequent infusions, ideally at intervals of at least 2 weeks. Further research is warranted to validate and expand upon these observations, offering new insights into the potential role of ketamine in the management of dysthymia.
ISSN:2319-5363
2583-4010